Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Rahmati

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Fitoterapia|June 24, 2010
Two new lathyrane type diterpenoids from Euphorbia aelleniiAbdul Majid Ayatollahi, Mustafa Ghanadian, Suleiman Afsharypuor, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 20, 2015
Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell LineSina Mohammadinejad, Abolfazl Akbarzadeh, Mohammad Rahmati-Yamchi, et al.
Biochemical Genetics|January 25, 2025
MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little HeroesMaryam Zamani Sani, Mohammad Mirzaei, Ali Mota, et al.
Artificial Cells, Nanomedicine, and Biotechnology|December 2, 2014
A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCRShirafkan Kordi, Nosratolah Zarghami, Abolfazl Akbarzadeh, et al.
Protein Expression and Purification|June 15, 2016
Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR)Bahman Akbari, Safar Farajnia, Nosratollah Zarghami, et al.
Cancer Cell International|August 3, 2024
Correction: MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcomeShahram Taeb, Davoud Rostamzadeh, Seyed Mohammad Amini, et al.
Cancer Cell International|September 7, 2021
Recombinant immunotoxins development for HER2-based targeted cancer therapiesReza Mahmoudi, Hassan Dianat-Moghadam, Mansour Poorebrahim, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 18, 2014
Comparison of inhibitory effects of 17-AAG nanoparticles and free 17-AAG on HSP90 gene expression in breast cancerMasoud Gandomkar Ghalhar, Abolfazl Akbarzadeh, Mohammad Rahmati, et al.
Artificial Cells, Nanomedicine, and Biotechnology|July 15, 2014
Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell lineSedigheh Fekri Aval, Abolfazl Akbarzadeh, Mohammad Rahmati Yamchi, et al.
Artificial Cells, Nanomedicine, and Biotechnology|September 30, 2016
An update clinical application of amniotic fluid-derived stem cells (AFSCs) in cancer cell therapy and tissue engineeringShiva Gholizadeh-Ghaleh Aziz, Ezzatollah Fathi, Mohammad Rahmati-Yamchi, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Fitoterapia|June 24, 2010
Two new lathyrane type diterpenoids from Euphorbia aelleniiAbdul Majid Ayatollahi, Mustafa Ghanadian, Suleiman Afsharypuor, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 20, 2015
Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell LineSina Mohammadinejad, Abolfazl Akbarzadeh, Mohammad Rahmati-Yamchi, et al.
Biochemical Genetics|January 25, 2025
MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little HeroesMaryam Zamani Sani, Mohammad Mirzaei, Ali Mota, et al.
Artificial Cells, Nanomedicine, and Biotechnology|December 2, 2014
A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCRShirafkan Kordi, Nosratolah Zarghami, Abolfazl Akbarzadeh, et al.
Protein Expression and Purification|June 15, 2016
Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR)Bahman Akbari, Safar Farajnia, Nosratollah Zarghami, et al.
Cancer Cell International|August 3, 2024
Correction: MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcomeShahram Taeb, Davoud Rostamzadeh, Seyed Mohammad Amini, et al.
Cancer Cell International|September 7, 2021
Recombinant immunotoxins development for HER2-based targeted cancer therapiesReza Mahmoudi, Hassan Dianat-Moghadam, Mansour Poorebrahim, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 18, 2014
Comparison of inhibitory effects of 17-AAG nanoparticles and free 17-AAG on HSP90 gene expression in breast cancerMasoud Gandomkar Ghalhar, Abolfazl Akbarzadeh, Mohammad Rahmati, et al.
Artificial Cells, Nanomedicine, and Biotechnology|July 15, 2014
Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell lineSedigheh Fekri Aval, Abolfazl Akbarzadeh, Mohammad Rahmati Yamchi, et al.
Artificial Cells, Nanomedicine, and Biotechnology|September 30, 2016
An update clinical application of amniotic fluid-derived stem cells (AFSCs) in cancer cell therapy and tissue engineeringShiva Gholizadeh-Ghaleh Aziz, Ezzatollah Fathi, Mohammad Rahmati-Yamchi, et al.
Pageof 14